170 related articles for article (PubMed ID: 23979756)
1. Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.
Marcos-Zambrano LJ; Escribano P; Rueda C; Zaragoza Ó; Bouza E; Guinea J
Antimicrob Agents Chemother; 2013 Nov; 57(11):5767-70. PubMed ID: 23979756
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.
Bougnoux ME; Dannaoui E; Accoceberry I; Angoulvant A; Bailly E; Botterel F; Chevrier S; Chouaki T; Cornet M; Dalle F; Datry A; Dupuis A; Fekkar A; Gangneux JP; Guitard J; Hennequin C; Le Govic Y; Le Pape P; Maubon D; Ranque S; Sautour M; Sendid B; Chandenier J
Antimicrob Agents Chemother; 2016 Aug; 60(8):5088-91. PubMed ID: 27297480
[TBL] [Abstract][Full Text] [Related]
3. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.
Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Moet GJ; Jones RN
J Clin Microbiol; 2010 May; 48(5):1592-9. PubMed ID: 20335424
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
5. Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods.
Meletiadis J; Geertsen E; Curfs-Breuker I; Meis JF; Mouton JW
Antimicrob Agents Chemother; 2016 Oct; 60(10):6173-8. PubMed ID: 27480850
[TBL] [Abstract][Full Text] [Related]
6. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.
Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257
[No Abstract] [Full Text] [Related]
7. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
Pfaller M; Boyken L; Hollis R; Kroeger J; Messer S; Tendolkar S; Diekema D
J Clin Microbiol; 2011 Feb; 49(2):624-9. PubMed ID: 21147948
[TBL] [Abstract][Full Text] [Related]
8. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
Axner-Elings M; Botero-Kleiven S; Jensen RH; Arendrup MC
J Clin Microbiol; 2011 Jul; 49(7):2516-21. PubMed ID: 21543574
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
[TBL] [Abstract][Full Text] [Related]
10. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
11. Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.
Marcos-Zambrano LJ; Escribano P; Sánchez-Carrillo C; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799221
[TBL] [Abstract][Full Text] [Related]
12. Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria.
Pfaller MA; Messer SA; Diekema DJ; Jones RN; Castanheira M
J Clin Microbiol; 2014 Jan; 52(1):108-14. PubMed ID: 24153129
[TBL] [Abstract][Full Text] [Related]
13. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.
Arendrup MC; Garcia-Effron G; Lass-Flörl C; Lopez AG; Rodriguez-Tudela JL; Cuenca-Estrella M; Perlin DS
Antimicrob Agents Chemother; 2010 Jan; 54(1):426-39. PubMed ID: 19884370
[TBL] [Abstract][Full Text] [Related]
14. Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates.
Espinel-Ingroff A; Cantón E; Pelaez T; Pemán J
Diagn Microbiol Infect Dis; 2011 May; 70(1):54-9. PubMed ID: 21513843
[TBL] [Abstract][Full Text] [Related]
15. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
Cretella D; Barber KE; King ST; Stover KR
J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
Khan Z; Ahmad S; Joseph L; Chandy R; Theyyathel A
J Chemother; 2011 Apr; 23(2):97-101. PubMed ID: 21571626
[TBL] [Abstract][Full Text] [Related]
17. Rezafungin
Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
[TBL] [Abstract][Full Text] [Related]
18. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
19. Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.
Arendrup MC; Rodriguez-Tudela JL; Park S; Garcia-Effron G; Delmas G; Cuenca-Estrella M; Gomez-Lopez A; Perlin DS
Antimicrob Agents Chemother; 2011 Apr; 55(4):1580-7. PubMed ID: 21245440
[TBL] [Abstract][Full Text] [Related]
20. Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.
Espinel-Ingroff A; Canton E; Peman J; Martín-Mazuelo E
Antimicrob Agents Chemother; 2010 Mar; 54(3):1347-50. PubMed ID: 20028814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
